Free Trial

Gallagher Fiduciary Advisors LLC Takes $352,000 Position in Lemonade, Inc. (NYSE:LMND)

Lemonade logo with Finance background

Gallagher Fiduciary Advisors LLC purchased a new stake in Lemonade, Inc. (NYSE:LMND - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 9,610 shares of the company's stock, valued at approximately $352,000.

Several other institutional investors and hedge funds also recently modified their holdings of the company. Barclays PLC boosted its position in Lemonade by 292.5% during the third quarter. Barclays PLC now owns 87,414 shares of the company's stock valued at $1,443,000 after purchasing an additional 65,144 shares during the last quarter. Tidal Investments LLC lifted its stake in Lemonade by 4.6% in the third quarter. Tidal Investments LLC now owns 45,631 shares of the company's stock valued at $752,000 after acquiring an additional 2,017 shares during the last quarter. Johnson & White Wealth Management LLC bought a new position in shares of Lemonade in the 4th quarter valued at about $234,000. Mandatum Life Insurance Co Ltd bought a new stake in shares of Lemonade in the 4th quarter valued at about $378,000. Finally, Nisa Investment Advisors LLC raised its holdings in shares of Lemonade by 4.9% in the 4th quarter. Nisa Investment Advisors LLC now owns 10,640 shares of the company's stock valued at $390,000 after purchasing an additional 500 shares during the period. 80.30% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research analysts have recently commented on LMND shares. Morgan Stanley downgraded Lemonade from an "equal weight" rating to an "underweight" rating and reduced their target price for the stock from $35.00 to $24.00 in a research note on Tuesday, April 8th. Piper Sandler decreased their price objective on shares of Lemonade from $44.00 to $34.00 and set a "neutral" rating on the stock in a report on Wednesday, February 26th. Finally, Keefe, Bruyette & Woods cut their target price on shares of Lemonade from $25.00 to $22.00 and set an "underperform" rating for the company in a research note on Tuesday, April 22nd. Four research analysts have rated the stock with a sell rating, one has assigned a hold rating and one has given a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average target price of $28.17.

View Our Latest Stock Report on LMND

Insiders Place Their Bets

In other news, major shareholder Softbank Group Capital Ltd sold 204,575 shares of the company's stock in a transaction that occurred on Monday, March 24th. The shares were sold at an average price of $37.08, for a total transaction of $7,585,641.00. Following the completion of the sale, the insider now owns 10,494,636 shares of the company's stock, valued at approximately $389,141,102.88. This represents a 1.91 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider John Sheldon Peters sold 1,899 shares of the company's stock in a transaction on Tuesday, March 4th. The stock was sold at an average price of $33.79, for a total value of $64,167.21. Following the sale, the insider now owns 87,609 shares of the company's stock, valued at approximately $2,960,308.11. This represents a 2.12 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 249,134 shares of company stock worth $9,234,003 in the last 90 days. Company insiders own 12.50% of the company's stock.

Lemonade Stock Up 1.0 %

Shares of Lemonade stock traded up $0.30 during trading on Tuesday, reaching $30.30. The company's stock had a trading volume of 4,812,308 shares, compared to its average volume of 1,921,244. Lemonade, Inc. has a 52 week low of $14.03 and a 52 week high of $53.85. The firm has a market cap of $2.22 billion, a PE ratio of -9.97 and a beta of 2.13. The business's 50-day moving average price is $31.30 and its 200-day moving average price is $33.99.

Lemonade (NYSE:LMND - Get Free Report) last announced its earnings results on Tuesday, May 6th. The company reported ($0.86) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.95) by $0.09. Lemonade had a negative net margin of 43.51% and a negative return on equity of 32.85%. During the same quarter last year, the firm posted ($0.67) EPS. The business's revenue for the quarter was up 27.0% on a year-over-year basis. Equities analysts predict that Lemonade, Inc. will post -3.03 earnings per share for the current year.

Lemonade Company Profile

(Free Report)

Lemonade, Inc provides various insurance products through various channels in the United States, Europe, and the United Kingdom. Its insurance products include stolen or damaged property, and personal liability that protects its customers if they are responsible for an accident or damage to another person or their property.

Further Reading

Institutional Ownership by Quarter for Lemonade (NYSE:LMND)

Should You Invest $1,000 in Lemonade Right Now?

Before you consider Lemonade, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lemonade wasn't on the list.

While Lemonade currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Free Today: Your Guide to Smarter Options Trades Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Big Moves: Profit-Taking, Price Targets & AI Potential
Buy Early: 3 Tech Trends With Millionaire-Making Potential
SMCI Stumbles on Earnings: Why Some Investors Still Want In

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines